Summary
Rigel Pharmaceuticals, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company.
Key Highlights
Rigel Pharmaceuticals, Inc. (Rigel or 'the company') is a clinical-stage drug development company that commercializes and sells novel, targeted drugs in immunology, inflammatory, autoimmune, oncology, and immuno-oncology related therapeutic areas. Its products include IgA Nephropathy, Autoimmune Hemolytic Anemia, and Immune Thrombocytopenic Purpura. The company conducts various clinical trials and receives approval from the US Food and Drug Administration (FDA) before implementing on various patients. Rigel Pharmaceuticals collaborates with various pharmaceutical companies for developing therapeutic drugs. It markets its products through partnerships in various geographical regions including the US, Europe, Asia, and Canada. The company is headquartered in South San Francisco, California, the US.
Scope
- Detailed information on Rigel Pharmaceuticals, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Rigel Pharmaceuticals, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Rigel Pharmaceuticals, Inc. including a breakdown and examination of key business segments
- Intelligence on Rigel Pharmaceuticals, Inc.'s mergers and acquisitions (MandA), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Rigel Pharmaceuticals, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends
Reasons to Buy
- Gain understanding of Rigel Pharmaceuticals, Inc. and the factors that influence its strategies.
- Track strategic initiatives of the company and latest corporate news and actions.
- Assess Rigel Pharmaceuticals, Inc. as a prospective partner, vendor or supplier.
- Support sales activities by understanding your customers' businesses better.
- Stay up to date on Rigel Pharmaceuticals, Inc.'s business structure, strategy and prospects.
'
Table of Contents
Company Snapshot
Rigel Pharmaceuticals, Inc.: Company Overview
Rigel Pharmaceuticals, Inc.: Overview and Key Facts
Rigel Pharmaceuticals, Inc.: Overview
Rigel Pharmaceuticals, Inc.: Key Facts
Rigel Pharmaceuticals, Inc.: Key Employees
Rigel Pharmaceuticals, Inc.: Key Employee Biographies
Rigel Pharmaceuticals, Inc.: Major Products and Services
Rigel Pharmaceuticals, Inc.: Company History
Rigel Pharmaceuticals, Inc.: Management Statement
Rigel Pharmaceuticals, Inc.: Key Competitors
Rigel Pharmaceuticals, Inc.: Company Analysis
Rigel Pharmaceuticals, Inc.: Business Description
Rigel Pharmaceuticals, Inc.: SWOT Analysis
Rigel Pharmaceuticals, Inc.: SWOT Overview
Rigel Pharmaceuticals, Inc.: Strengths
Rigel Pharmaceuticals, Inc.: Weaknesses
Rigel Pharmaceuticals, Inc.: Opportunities
Rigel Pharmaceuticals, Inc.: Threats
Rigel Pharmaceuticals, Inc.: Corporate Financial Deals Activity
Rigel Pharmaceuticals, Inc.: Financial Deals Overview
Rigel Pharmaceuticals, Inc.: Targets and Partners
Rigel Pharmaceuticals, Inc.: Top Deals 2018 - 2022YTD*
Rigel Pharmaceuticals, Inc.: Advisors
Rigel Pharmaceuticals, Inc.: Top Legal Advisors
Rigel Pharmaceuticals, Inc.: Top Financial Advisors
Rigel Pharmaceuticals, Inc.: Capital Raising
Rigel Pharmaceuticals, Inc.: Partnership
Rigel Pharmaceuticals, Inc.: Recent Developments
Rigel Pharmaceuticals, Inc.: News and Events Summary
Rigel Pharmaceuticals, Inc.: Corporate Governance
Rigel Pharmaceuticals, Inc.: Financial Performance
Rigel Pharmaceuticals, Inc.: Market Developments
Rigel Pharmaceuticals, Inc.: Research & Development
Rigel Pharmaceuticals, Inc.: Strategy and Operations
Appendix
Contact Us
Methodology
About MarketLine
List of Tables
Table 1: Rigel Pharmaceuticals, Inc.: Key Facts
Table 2: Rigel Pharmaceuticals, Inc.: Key Employees
Table 3: Rigel Pharmaceuticals, Inc.: Company History
Table 4: Rigel Pharmaceuticals, Inc.: Key Competitors
Table 5: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Table 6: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Table 7: Rigel Pharmaceuticals, Inc.: Targets and Partners
Table 8: Rigel Pharmaceuticals, Inc.: Top Deals 2018 - 2022YTD*
Table 9: Rigel Pharmaceuticals, Inc.: Legal Advisor Ranking by Value (US$m)
Table 10: Rigel Pharmaceuticals, Inc.: Financial Advisor Ranking by Value (US$m)
Table 11: Rigel Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Table 12: Rigel Pharmaceuticals, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Table 13: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Table 14: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
Table 15: Rigel Pharmaceuticals, Inc.: News and Events Summary
Table 16: Rigel Pharmaceuticals, Inc.: Corporate Governance
Table 17: Rigel Pharmaceuticals, Inc.: Financial Performance
Table 18: Rigel Pharmaceuticals, Inc.: Market Developments
Table 19: Rigel Pharmaceuticals, Inc.: Research & Development
Table 20: Rigel Pharmaceuticals, Inc.: Strategy and Operations
List of Figures
Figure 1: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (TTM*)
Figure 2: Rigel Pharmaceuticals, Inc.: Deal Activity by Deal Type - Volume (2018 - YTD*2022)
Figure 3: Rigel Pharmaceuticals, Inc.: Capital Raising Volume and Value Trend (2018 - YTD*2022)
Figure 4: Rigel Pharmaceuticals, Inc.: Capital Raising by Deal Type (2018 - YTD*2022)
Figure 5: Rigel Pharmaceuticals, Inc.: Partnership Volume and Value Trend (2018 - YTD*2022)
Figure 6: Rigel Pharmaceuticals, Inc.: Partnership Trend by Deal Type (2018 - YTD*2022)
